HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chaisson, R E Articles by Carlson, J R Search for Related Content PubMed PubMed Citation Articles by Chaisson, R E Articles by Carlson, J R

Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco.

R E Chaisson, A R Moss, R Onishi, D Osmond and J R Carlson

To investigate the risk of infection with the human immunodeficiency virus (HIV) in San Francisco, the prevalence of antibodies to HIV was determined in 281 heterosexual intravenous drug users recruited from community-based settings. Ten per cent of subjects had ELISA and Western blot confirmed seropositivity for antibodies (95 per cent CI 6.8-14.2 per cent). Analysis of behavioral factors revealed an increased risk of seropositivity in addicts who reported regularly sharing needles when injecting, particularly those sharing with two or more persons (odds ratio = 5.43; 95 per cent CI 1.08-52.5). Blacks and Latinos also had a greater prevalence of seropositivity than Whites, and this finding persisted after adjustment for needle sharing (adjusted odds ratio = 2.8; 95 per cent CI .84-8.59). Seropositivity was not associated with age, sex, duration of drug use, or history of prostitution. These data indicate that a new epidemic of AIDS (acquired immunodeficiency syndrome) in intravenous drug users, similar to that which has occurred among homosexuals in San Francisco, is possible. The relatively low seroprevalence in 1985 provides health officials an important opportunity to intervene and attempt to prevent widespread infection of drug users with HIV.

This article has been cited by other articles:

				C. M. Fuller, L. N. Borrell, C. A. Latkin, S. Galea, D. C. Ompad, S. A. Strathdee, and D. Vlahov Effects of Race, Neighborhood, and Social Network on Age at Initiation of Injection Drug Use Am J Public Health, April 1, 2005; 95(4): 689 - 695. [Abstract] [Full Text] [PDF]

				M. J. Robertson, R. A. Clark, E. D. Charlebois, J. Tulsky, H. L. Long, D. R. Bangsberg, and A. R. Moss HIV Seroprevalence Among Homeless and Marginally Housed Adults in San Francisco Am J Public Health, July 1, 2004; 94(7): 1207 - 1217. [Abstract] [Full Text] [PDF]

				S. Deren, S.-Y. Kang, H. M. Colon, J. F. Andia, R. R. Robles, D. Oliver-Velez, and A. Finlinson Migration and HIV Risk Behaviors: Puerto Rican Drug Injectors in New York City and Puerto Rico Am J Public Health, May 1, 2003; 93(5): 812 - 816. [Abstract] [Full Text] [PDF]

				J. Lopez-Zetina, W. Ford, M. Weber, S. Barna, T. Woerhle, P. Kerndt, and E. Monterroso Predictors of syphilis seroreactivity and prevalence of HIV among street recruited injection drug users in Los Angeles County, 1994-6 Sex Transm Inf, December 1, 2000; 76(6): 462 - 469. [Abstract] [Full Text] [PDF]

				L. O. Gostin, Z. Lazzarini, T. S. Jones, and K. Flaherty Prevention of HIV/AIDS and Other Blood-Borne Diseases Among Injection Drug Users: A National Survey on the Regulation of Syringes and Needles JAMA, January 1, 1997; 277(1): 53 - 62. [Abstract] [PDF]

				K. E. Nelson, D. Vlahov, L. Solomon, S. Cohn, and A. Munoz Temporal Trends of Incident Human Immunodeficiency Virus Infection in a Cohort of Injecting Drug Users in Baltimore, Md Arch Intern Med, June 26, 1995; 155(12): 1305 - 1311. [Abstract] [PDF]

				S. Decker and R. Rosenfeld Intravenous Drug Use and the AIDS Epidemic: Findings from a 20-City Sample of Arrestees Crime Delinquency, October 1, 1992; 38(4): 492 - 509. [Abstract]

				W. El-Sadr, R. R. Goetz, S. Sorrell, M. Joseph, A. Ehrhardt, and J. M. Gorman Clinical and Laboratory Correlates of Human Immunodeficiency Virus Infection in a Cohort of Intravenous Drug Users From New York, NY Arch Intern Med, August 1, 1992; 152(8): 1653 - 1659. [Abstract] [PDF]

				K. E. Nelson, D. Vlahov, S. Cohn, A. Lindsay, L. Solomon, and J. C. Anthony Human Immunodeficiency Virus Infection in Diabetic Intravenous Drug Users JAMA, October 23, 1991; 266(16): 2259 - 2261. [Abstract] [PDF]

				A. P. West Drug Abuse Treatment as a Strategy to Prevent Human Immunodeficiency Virus Infection Among Intravenous Drug Users: How Can We Maximize Prevention of Infection? Arch Intern Med, August 1, 1991; 151(8): 1493 - 1496. [Abstract] [PDF]

				T. Hammett, D. Hunt, M. Gross, W. Rhodes, and S. Moini Stemming the Spread of HIV among IV Drug Users, their Sexual Partners, and Children: Issues and Opportunities for Criminal Justice Agencies Crime Delinquency, January 1, 1991; 37(1): 101 - 124. [Abstract]

				J. Casado-Flores, A. Bano-Rodrigo, and E. Romero Social and Medical Problems in Children of Heroin-Addicted Parents: A Study of 75 Patients Arch Pediatr Adolesc Med, September 1, 1990; 144(9): 977 - 979. [Abstract] [PDF]

				G. F. Lemp, S. F. Payne, G. W. Rutherford, N. A. Hessol, W. Winkelstein Jr, J. A. Wiley, A. R. Moss, R. E. Chaisson, R. T. Chen, D. W. Feigal Jr, et al. Projections of AIDS Morbidity and Mortality in San Francisco JAMA, March 16, 1990; 263(11): 1497 - 1501. [Abstract] [PDF]

				C. B. McCOY and E. KHOURY Drug Use and the Risk of AIDS American Behavioral Scientist, March 1, 1990; 33(4): 419 - 431.

				H. V. McCOY, C. Y. McKAY, L. HERMANNS, and S. LAI Sexual Behavior and the Risk of HIV Infection American Behavioral Scientist, March 1, 1990; 33(4): 432 - 450.

				D. D. CHITWOOD and M. COMERFORD Drugs, Sex, and AIDS Risk: Cocaine Users Versus Opiate Users American Behavioral Scientist, March 1, 1990; 33(4): 465 - 477.

				J. B. PAGE Shooting Scenarios and Risk of HIV-1 Infection American Behavioral Scientist, March 1, 1990; 33(4): 478 - 490.

				S. C. Kalichman, J. A. Kelly, and J. S. St. Lawrence Factors Influencing Reduction of Sexual Risk Behaviors for Human Immunodeficiency Virus Infection: a Review Sexual Abuse: A Journal of Research and Treatment, January 1, 1990; 3(2): 129 - 148. [Abstract] [PDF]

				R. A. Hahn, I. M. Onorato, T. S. Jones, and J. Dougherty Prevalence of HIV Infection Among Intravenous Drug Users in the United States JAMA, May 12, 1989; 261(18): 2677 - 2684. [Abstract] [PDF]

				G. A. Richwald, M. Schneider-Mufnoz, and R. B. Valdez Are Condom Instructions in Spanish Readable? Implications for AIDS Prevention Activities for Hispanics Hispanic Journal of Behavioral Sciences, February 1, 1989; 11(1): 70 - 82. [Abstract]

				R. E. Chaisson, P. Bacchetti, D. Osmond, B. Brodie, M. A. Sande, and A. R. Moss Cocaine Use and HIV Infection in Intravenous Drug Users in San Francisco JAMA, January 27, 1989; 261(4): 561 - 565. [Abstract] [PDF]

				S. H. Weiss Links Between Cocaine and Retroviral Infection JAMA, January 27, 1989; 261(4): 607 - 609. [Abstract] [PDF]

				W. Koff and D. Hoth Development and testing of AIDS vaccines Science, July 22, 1988; 241(4864): 426 - 432. [Abstract] [PDF]

				J. Curran, H. Jaffe, A. Hardy, W. Morgan, R. Selik, and T. Dondero Epidemiology of HIV infection and AIDS in the United States Science, February 5, 1988; 239(4840): 610 - 616. [Abstract] [PDF]

				L. S. Brown Jr, D. L. Murphy, and B. J. Primm Needle Sharing and AIDS in Minorities JAMA, September 18, 1987; 258(11): 1474 - 1475. [Abstract] [PDF]